MAIA ▼ -0.8% - MAIA Biotechnology, Inc.
$MAIA - MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer
07-OCT-2026 08:15 AM ET
Share this post
More filings for $MAIA
MAIA ▼ -1.5% - MAIA Biotechnology, Inc.Sep 23, 2026MAIA ▲ +3.0% - MAIA Biotechnology, Inc.Sep 16, 2026MAIA ▲ +3.6% - MAIA Biotechnology, Inc.Sep 15, 2026
View full $MAIA filing history →💬 Comments
Loading comments…
Leave a comment